检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王辛[1] 李学奇[1] 夏洪远[1] 白晓鹏[1]
机构地区:[1]哈尔滨医科大学附属第四医院心内科,黑龙江哈尔滨150001
出 处:《现代生物医学进展》2015年第30期5970-5973,5815,共5页Progress in Modern Biomedicine
基 金:黑龙江省博士后资助项目(LBH-Z12169)
摘 要:重叠支架置入术是临床上用来治疗冠状动脉弥漫性长病变的常用方法,以往曾采取重叠裸金属支架置入术,但其临床预后不佳,目前较为常用的重叠药物洗脱支架置入术被认为相对安全、有效,但仍存在许多潜在问题。本文介绍了适合使用重叠支架置入术进行治疗的冠状动脉病变的特点,回顾了重叠裸金属支架的临床应用情况,阐述了近年来药物洗脱支架的发展以及重叠药物洗脱支架置入术的优势,比较了四种负载不同药物的药物洗脱支架同种重叠置入后的临床疗效,观察了异种药物洗脱支架混合重叠置入后的临床特点和支架重叠段对临床预后的影响,分析了重叠支架置入术与几种其它治疗冠状动脉弥漫性长病变方法的应用区别,并对新一代药物支架的重叠应用进行了展望。Overlapping stent implantation is a common method in the treatment of coronary artery diffuse long lesions.Overlapping bare-metal stent implantation was widely used in the past, but the clinical prognosis was not good enough. At present,overlapping drug-eluting stents are usually used. Although overlapping bare-metal stent implantation is considered relatively safe and effective, there are still many potential problems. This article introduces the characteristics of coronary artery lesions which are suitable to use overlapping stent implantation for treatment, reviewes the clinical application of overlapping bare-metal stents, expounds the development of drug-eluting stents in recent years as well as the advantage of the overlapping drug-eluting stent implantation, compares the clinical curative effect of overlapping homogeneous drug-eluting stents which load different types of drugs, observes the clinical characteristics of overlapping heterogeneous drug-eluting stents and the influence of overlapping parts of stents on clinical outcomes,analyzes the difference of application between overlapping stents and several other ways of treating coronary artery diffuse long lesions and looks forward to the application of a new generation of overlapping drug-eluting stents.
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.252.155